Clinical Trials Browser

Phase 3 × INDUSTRY × Dehydroepiandrosterone × Clear all

NCT03740945 2020-07-31

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Phase 3 Withdrawn

Breast Neoplasms, Atrophic Vaginitis